Objective: To discern highly aggressive intratumoral areas among lung adenocarcinoma (LUAD) and its impact on occult nodal metastases and the recurrence rate with radiomic analysis.

Methods: This prospective dual-institution study analyzed clinical information and high-resolution preoperative CT of 528 patients from institution A and 249 patients from institution B. We extracted radiomic features and performed pathologic evaluations for resected tumors, based on the 2020 International Association for the Study of Lung Cancer (IASLC) classification. Prediction models were developed to discern micropapillary and solid patterns within LUAD using clinical and radiomic features from institution A through logistic analysis.

Results: Six selected CT radiomic features, sex, CTR (consolidation-to-tumor ratio), and solid diameter were selected to develop the prediction models. A composite model of radiomic and clinical characteristics outperformed radiomics-only and clinical-only models (AUC, 95% CI; the composite model: 0.84 [0.81-0.87]; the radiomics model: 0.82 [0.78-0.87]; the clinical model: 0.80 [0.76-0.83]) in institution A. External validation was performed with institution B cohort, showing even better results (AUC, 95% CI; the composite model: 0.91 [0.87-0.94]; the radiomics model: 0.89 [0.84-0.94]; the clinical model: 0.88 [0.84-0.92]).

Conclusions: Our study underscores the potential of radiomics to preoperatively predict aggressive histologic patterns in LUAD, enabling precise treatment planning and prognosis estimation.

Key Points: Question Can any adjuvant methods address the limitations of core needle biopsies, which are invasive and may not capture the full heterogeneity of lung adenocarcinoma? Findings In a prospective study of 528 patients with cT1N0M0 lung adenocarcinoma, a composite model of clinical characteristics, conventional CT findings, and radiomics features predicted high-grade cancers. Clinical relevance Preoperative non-invasive diagnosis of histologically high-grade tumors using radiomics analysis offers crucial information for the treatment of lung adenocarcinoma with respect to occult lymph node metastasis and recurrence rate.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-025-11397-4DOI Listing

Publication Analysis

Top Keywords

lung adenocarcinoma
16
composite model
16
radiomic features
12
heterogeneity lung
8
recurrence rate
8
528 patients
8
patients institution
8
prediction models
8
patterns luad
8
model
8

Similar Publications

In vitro study of a siRNA delivery liposome constructed with an ionizable cationic lipid.

Zhong Nan Da Xue Xue Bao Yi Xue Ban

October 2024

Department of Pharmaceutical Engineering, Chemistry and Chemical Engineering, Central South University, Changsha 410083.

Objectives: Small interfering RNA (siRNA) can silence disease-related genes through sequence-specific RNA interference (RNAi). Cationic lipid-based liposomes effectively deliver nucleic acids into the cytoplasm but often exhibit significant toxicity. This study aims to synthesize a novel ionizable lipid, Nε-laruoyl-lysine amide (LKA), from natural amino acids, constructed LKA-based liposomes, and perform physicochemical characterization and cell-based experiments to systematically evaluate the potential of these ionizable lipid-based liposomes for nucleic acid delivery.

View Article and Find Full Text PDF

OncoFlow: A Multiplexed Microfluidic Platform for Personalized Drug Sensitivity Assessment.

N Biotechnol

March 2025

The Mina & Everard Goodman Faculty of Life Sciences and the Institute for Nanotechnology and Advanced Materials, Bar Ilan University, Ramat-Gan, Israel. Electronic address:

While biomarker-guided treatments and NGS-based approaches are refining precision medicine, they are not universally applicable. The gap between the genomic characterization of tumors and their functional behavior is becoming increasingly evident. There is an escalating demand for functional assays that can customize cancer treatments for individual patients and bridge this gap.

View Article and Find Full Text PDF

Rapid diagnosis of lung cancer by multi-modal spectral data combined with deep learning.

Spectrochim Acta A Mol Biomol Spectrosc

March 2025

State Key Laboratory of Electromechanical Integrated Manufacturing of High-performance Electronic Equipment, School of Electro-Mechanical Engineering, Xidian University, Xi'an, Shaanxi 710071, China. Electronic address:

Lung cancer is a malignant tumor that poses a serious threat to human health. Existing lung cancer diagnostic techniques face the challenges of high cost and slow diagnosis. Early and rapid diagnosis and treatment are essential to improve the outcome of lung cancer.

View Article and Find Full Text PDF

Residential greenness, air pollution, genetic predisposition and the risk of lung cancer.

Ecotoxicol Environ Saf

March 2025

Department of Respiratory Medicine, National Key Clinical Specialty, Branch of National Clinical Research Center for Respiratory Disease, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, Hunan 410008, China. Electronic address:

Background: Growing evidence suggests that greenness is associated with multiple health outcomes, but its association with lung cancer risk remains limited and far from consistent. In particular, it is unclear whether this association varies across different types of lung cancer and whether it is influenced by factors such as genetics, air pollution, and physical activity.

Method: This prospective cohort study included 425108 participants aged 37-73 years from the UK Biobank.

View Article and Find Full Text PDF

While immunotherapy has shown some efficacy in lung adenocarcinoma (LUAD) patients, many respond only partially or not at all. One limitation in improving outcomes is the lack of a complete understanding of immune checkpoint regulation. Here, we investigated a possible link between an environmental chemical receptor implicated in lung cancer and immune regulation, the AhR, a known but counterintuitive mediator of immunosuppression (interferon (IFN)-γ), and regulation of two immune checkpoints (PD-L1 and IDO).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!